Bioanalytical Systems (BASI) Reports Q2 Loss of $0.03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BASi Reports Second Quarter Results
May 12, 2016 9:56 AM EDTWEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Bioanalytical Systems, Inc. (NASDAQ: BASI) (BASi or the Company) today announced financial results for the second quarter and first six months of fiscal 2016.
Second Quarter Results
For the three months ended March 31, 2016, revenue was $5,339,000 a 6.8% decrease from $5,726,000 in the second quarter of fiscal 2015, but a 9.1% increase sequentially from the first quarter of fiscal 2016.
Service revenue for the second quarter of fiscal 2016 decreased 10.5% to $4,053,000 compared to $4,530,000 for the same period in fiscal 2015. Preclinical services revenue declined 7% due to customer delays and Bioanalytical revenue... More
